Analysis of clinical applicability of the breast cancer nomogram for positive sentinel lymph node: The Canadian experience

Annals of Surgical Oncology

Volumn 15, Issue 9, 2008, Pages 2562-2567

  Poirier, Éric ^a,b   Sideris, Lucas ^c   Dubé, Pierre ^c   Drolet, Pierre ^d   Meterissian, Sarkis H ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Axillary lymph node dissection; Breast cancer; Breast Cancer Nomogram; Sentinel node

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANADA; DECISION MAKING; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; NOMOGRAM; PRACTICE GUIDELINE; RECEIVER OPERATING CHARACTERISTIC; SENTINEL LYMPH NODE;

BREAST NEOPLASMS; CANADA; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 50049130707     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0033-9     Document Type: Article

References (24)

1. GH Lyman AE Giuliano MR Somerfield 2005 American Society of Clinical Oncology, American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 7703 20
2. B Cady MD Stone JG Schuler 1996 The new era in breast cancer: invasion, size and nodal involvement dramatically decreasing as a result of mammographic screening Arch Surg 131 301 8
3. A Lucci LM McCall PD Beitsch 2007 Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011 J Clin Oncol 25 3657 63
4. B Fisher C Redmond E Fisher 1985 Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation N Engl J Surg 312 674 81
5. B Cady 1997 Case against axillary lymphadenectomy for most patients with infiltrating breast cancer J Surg Oncol 66 7 10
6. KJ Van Zee D-ME Manasseh JL Bevilacqua 2003 A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel lymph node biopsy Ann Surg Oncol 10 1140 51
7. L Kocsis M Svébis G Boross 2004 Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients Am Surg 70 1019 24
8. NK Soni HL Carmalt DJ Gillett 2005 Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity Eur J Surg Oncol 31 958 64
9. ML Smidt DM Kuster GJ van der Wilt 2005 Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastasis in breast cancer patients in the Netherlands? Ann Surg Oncol 12 1066 72
10. AC Degnim KA Griffith MS Sabel 2003 Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients Cancer 98 2307 15
11. MC Specht MW Kattan M Gonen 2005 Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram Ann Surg Oncol 12 654 9
12. MH Cripe LC Beran WC Liang 2006 The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram Am J Surg 192 484 7
13. LA Lambert GD Ayers RF Hwang 2006 Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastasis after a positive sentinel node biopsy Ann Surg Oncol 13 310 20
14. J Zgajnar A Perhavec M Hocevar 2007 Low performance of the MSKCC nomogram in preoperatively ultrasonically negative axillary lymph node in breast cancer patients J Surg Oncol 96 547 53
15. R Ponzone F Maggiorotto L Mariani 2007 Comparison of two models for the prediction of nonsentinel node metastasis in breast cancer Am J Surg 193 686 92
16. S Alran Y De Rycke V Fourchotte 2007 Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy Ann Surg Oncol 14 2195 201
17. A Pal E Provenzano SW Duffy 2007 A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive Br J Surg 95 302 9
18. Klar M, Jochmann A, Foeldi M, et al. The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population. Breast Cancer Res Treat 2008; Jan 3 (Epub ahead of print)
19. JE Fischer LM Bachman R Jaeschke 2003 A reader's guide to the interpretation of diagnostic test properties: clinical example of sepsis Intensive Care Med 29 1043 51
20. RB Benson GQ della Rovere 2007 Axilla Management Consensus Group (2007). Management of the axilla in women with breast cancer Lancet Oncol 8 331 48
21. RK Orr 1999 The impact of prophylactic axillary node dissection on breast cancer survival: a Bayesian meta-analysis Ann Surg Oncol 6 109 16
22. National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32: a randomized Phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node negative breast cancer patients. http://www.nsabp.pitt.edu / (accessed Feb 2008)
23. V Glimberty 2006 International Breast Cancer Study Group trial of sentinel node biopsy J Clin Oncol 24 210 1
24. American College of Surgeon Oncology Group (ACOSOG) Z0011. A randomised study of axillary node dissection in women with clinical T1-2, N0, M0 breast cancer who have a positive sentinel node. http://www.acosog.org/synopses/ Z0011_Synopsis.pdf / (accessed June 2008)